Zydus Settles On Revlimid In US
Agreement Brings To An End Indian Firm's Lenalidomide Litigation
Zydus Cadila has settled US patent litigation with Celgene over its proposed lenalidomide generic, marking the latest in a line of settlements over the Revlimid brand.
